Center for Strategic & International Studies: Protecting the United States from the Health Security Risk of Global Tuberculosis
In this report, Audrey Jackson, a senior fellow with the CSIS Global Health Policy Center, discusses the global spread of tuberculosis, including drug-resistant strains, writing, “To be effective in protecting Americans from a costly and potentially deadly disease, the U.S. government must address TB and drug-resistant TB both domestically and globally.” Jackson makes several recommendations for the Trump administration and Congress to “invest strategically in domestic and global TB programs and research and development (R&D) that will contribute to ending the TB epidemic” (7/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.